aap Implantate AG
aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides hole screws and Repro Bone materials. The company sells its products directly to hospitals, purchasing groups, and hospital… Read more
aap Implantate AG (AAQ1) - Total Liabilities
Latest total liabilities as of June 2025: €4.60 Million EUR
Based on the latest financial reports, aap Implantate AG (AAQ1) has total liabilities worth €4.60 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
aap Implantate AG - Total Liabilities Trend (2016–2024)
This chart illustrates how aap Implantate AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
aap Implantate AG Competitors by Total Liabilities
The table below lists competitors of aap Implantate AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Live Ventures Inc
NASDAQ:LIVE
|
USA | $293.93 Million |
|
SLP Resources Bhd
KLSE:7248
|
Malaysia | RM22.52 Million |
|
PCC Exol SA
WAR:PCX
|
Poland | zł476.31 Million |
|
Yw Company Limited
KQ:051390
|
Korea | ₩14.27 Billion |
|
Avonmore Capital & Management Services Limited
NSE:AVONMORE
|
India | ₹841.60 Million |
|
Eureka Design Public Company Limited
BK:UREKA
|
Thailand | ฿324.34 Million |
|
Airthings ASA
PINK:ARTGF
|
USA | $13.66 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down aap Implantate AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how aap Implantate AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for aap Implantate AG (2016–2024)
The table below shows the annual total liabilities of aap Implantate AG from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €5.38 Million | -41.46% |
| 2023-12-31 | €9.18 Million | +24.05% |
| 2022-12-31 | €7.40 Million | -27.28% |
| 2021-12-31 | €10.18 Million | +8.12% |
| 2020-12-31 | €9.41 Million | +26.89% |
| 2019-12-31 | €7.42 Million | +1.60% |
| 2018-12-31 | €7.30 Million | -7.69% |
| 2017-12-31 | €7.91 Million | -12.84% |
| 2016-12-31 | €9.07 Million | -- |